Underwriters have a 30-day option to buy an additional 1.8 million shares. Beta Bionics also agreed to sell 1 million shares in a private placement to an existing investor at $17 per share. Beta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback